These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11195622)

  • 1. Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study.
    Onat A; Sansoy V; Yildirim B
    Clin Cardiol; 2001 Jan; 24(1):9-14. PubMed ID: 11195622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein.
    Koba S; Hirano T; Sakaue T; Takeuchi H; Adachi M; Katagiri T
    Coron Artery Dis; 2002 Aug; 13(5):255-62. PubMed ID: 12394649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol.
    Bersot TP; Palaoğlu KE; Mahley RW
    Anadolu Kardiyol Derg; 2002 Dec; 2(4):315-22. PubMed ID: 12460830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study.
    Imke C; Rodriguez BL; Grove JS; McNamara JR; Waslien C; Katz AR; Willcox B; Yano K; Curb JD
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1718-22. PubMed ID: 15947240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in triglyceride levels and risk for coronary heart disease in young men.
    Tirosh A; Rudich A; Shochat T; Tekes-Manova D; Israeli E; Henkin Y; Kochba I; Shai I
    Ann Intern Med; 2007 Sep; 147(6):377-85. PubMed ID: 17876021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women.
    Onat A; Ceyhan K; Sansoy V; Basar O; Erer B; Uysal O; Hergenç G
    Int J Cardiol; 2002 Nov; 86(1):61-9. PubMed ID: 12243850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Ordovas JM; Cohn SD; Schaefer MM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):871-82. PubMed ID: 8071609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.